The Rejuvenate and ABG II are modular hip stems sold and distributed by Stryker. These hip stems were designed to allow a doctor to fit a hip implant device to a patient’s unique anatomy. The Rejuvenate and ABG II are not metal-on-metal hip devices; however, due to the design of the modular neck, they can cause the same types of serious injuries in recipients such as Adverse Local Tissue Reaction (ALTR), including pseudotumors and metallosis.
Metallosis develops when metal debris from the device is released into the surrounding tissue, which can cause pain and swelling at the implant site, as well as potentially more harmful side effects including bone deterioration and metal toxicity.
Rejuvenate is also associated with an early failure rate, requiring many patients to undergo revision surgery.
In 2012, Stryker implemented a voluntary recall of the Rejuvenate and ABG II modular neck stems due to potential risks associated with fretting and corrosion at the modular neck junction, a malfunction which could ultimately cause patients to develop ALTR and its accompanying health issues.
If you are an implant recipient of the Stryker Rejuvenate or ABG II modular neck stems and have developed signs or symptoms of ALTR or had to undergo revision surgery due to early failure of your device, please contact Slack Davis Sanger for a free consultation. Our team of experienced professionals includes a full-time legal nurse consultant, as well as medical device attorneys who have successfully fought cases against companies such as Guidant Corporation, Smith & Nephew, Sulzer Orthopedics, American Home Products, Bayer, Merck, Wyeth and others.